Enliven Therapeutics ELVN
NASDAQ ELVN
$46.21 +0.37 (+0.81%)
At close: Oct 1, 2026 · 4:00 PM EDT

Enliven Therapeutics (ELVN) Preferred Dividend Payments (2020)

Updated

Enliven Therapeutics' Preferred Dividend Payments was $7.9 million in FY2021, up 0.5% from $7.86 million in FY2020.

Analysis

Enliven Therapeutics (ELVN) Preferred Dividend Payments (2020) Analysis & Trends

  • Per Business Quant data, Preferred Dividend Payments in earlier years was $7.86 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Enliven Therapeutics 3.36 Bn 3.36 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -42,000.00
Jun 30, 2020 42,000.00
Mar 31, 2020 7.86 Mn
API Access

Enliven Therapeutics Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=ELVN&period=max&api_key=YOUR_API_KEY